These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort. Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863 [TBL] [Abstract][Full Text] [Related]
25. New advances in the genetics of pheochromocytoma and paraganglioma syndromes. Gimenez-Roqueplo AP Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078 [TBL] [Abstract][Full Text] [Related]
26. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma. Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058 [TBL] [Abstract][Full Text] [Related]
27. [Genetics of paragangliomas and pheochromocytomas]. Favier J; Gimenez-Roqueplo AP Med Sci (Paris); 2012; 28(6-7):625-32. PubMed ID: 22805139 [TBL] [Abstract][Full Text] [Related]
28. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Welander J; Söderkvist P; Gimm O Endocr Relat Cancer; 2011 Dec; 18(6):R253-76. PubMed ID: 22041710 [TBL] [Abstract][Full Text] [Related]
30. Pheochromocytoma: an update on genetics and management. Karagiannis A; Mikhailidis DP; Athyros VG; Harsoulis F Endocr Relat Cancer; 2007 Dec; 14(4):935-56. PubMed ID: 18045948 [TBL] [Abstract][Full Text] [Related]
31. Genetics of pheochromocytomas and paragangliomas. Opocher G; Schiavi F Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163 [TBL] [Abstract][Full Text] [Related]
32. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665 [TBL] [Abstract][Full Text] [Related]
33. Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas. Kang HC; Kim IJ; Park JH; Shin Y; Jang SG; Ahn SA; Park HW; Lim SK; Oh SK; Kim DJ; Lee KW; Choi YS; Park YJ; Lee MR; Kim DW; Park JG Oncol Rep; 2005 Oct; 14(4):879-83. PubMed ID: 16142346 [TBL] [Abstract][Full Text] [Related]
34. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. Jochmanová I; Yang C; Zhuang Z; Pacak K J Natl Cancer Inst; 2013 Sep; 105(17):1270-83. PubMed ID: 23940289 [TBL] [Abstract][Full Text] [Related]
35. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma. Moraitis AG; Martucci VL; Pacak K Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662 [TBL] [Abstract][Full Text] [Related]
36. Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas. Krawczyk A; Hasse-Lazar K; Pawlaczek A; Szpak-Ulczok S; Krajewska J; Paliczka-Cieślak E; Jurecka-Lubieniecka B; Roskosz J; Chmielik E; Ziaja J; Cierpka L; Peczkowska M; Preibisz A; Januszewicz A; Otto M; Jarzab B Endokrynol Pol; 2010; 61(1):43-8. PubMed ID: 20205103 [TBL] [Abstract][Full Text] [Related]
37. Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study. Favier J; Meatchi T; Robidel E; Badoual C; Sibony M; Nguyen AT; Gimenez-Roqueplo AP; Burnichon N Mod Pathol; 2020 Jan; 33(1):57-64. PubMed ID: 31383958 [TBL] [Abstract][Full Text] [Related]
38. Mutation screening in a Norwegian cohort with pheochromocytoma. Sjursen W; Halvorsen H; Hofsli E; Bachke S; Berge A; Engebretsen LF; Falkmer SE; Falkmer UG; Varhaug JE Fam Cancer; 2013 Sep; 12(3):529-35. PubMed ID: 23407919 [TBL] [Abstract][Full Text] [Related]
39. Frequent genetic changes in childhood pheochromocytomas. De Krijger RR; Petri BJ; Van Nederveen FH; Korpershoek E; De Herder WW; De Muinck Keizer-Schrama SM; Dinjens WN Ann N Y Acad Sci; 2006 Aug; 1073():166-76. PubMed ID: 17102083 [TBL] [Abstract][Full Text] [Related]
40. Genetics and biology of pheochromocytoma. Mannelli M; Simi L; Gaglianò MS; Opocher G; Ercolino T; Becherini L; Parenti G Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):160-5. PubMed ID: 17427103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]